Who Is a Candidate for MVD Surgery for Hemifacial Spasm?
At a Glance
A good candidate for microvascular decompression, or MVD, usually has clinically confirmed primary hemifacial spasm that significantly affects daily life, especially when Botox is ineffective, short-lasting, or poorly tolerated. Doctors also assess MRI findings, overall health, and surgical risks.
In this answer
4 sections
A good candidate for microvascular decompression (MVD)—a surgery that relieves pressure on the facial nerve—is someone with a confirmed clinical diagnosis of primary hemifacial spasm whose symptoms significantly impact their quality of life. Typically, candidates have tried botulinum toxin (Botox) injections but found them ineffective, short-lasting, or intolerable. Candidacy is not based on a single test; it is a highly individualized decision based on your clinical symptoms, imaging results to rule out other conditions, and your overall health to safely undergo general anesthesia and surgery.
Moving Beyond Botox
For most people with hemifacial spasm, botulinum toxin injections are the first line of treatment. These injections provide temporary relief by paralyzing the hyperactive facial muscles. On average, the benefit lasts around 15 weeks (roughly three to four months), though this varies depending on the individual, the dose, and the injection pattern [1][2].
You may become a strong candidate for MVD surgery if your experience with Botox changes over time. Surgery is often considered when:
- Injections stop working: The spasms may no longer respond to the medication, or the relief may wear off far too quickly [1].
- Side effects become intolerable: You might develop severe, though usually temporary, facial weakness, drooping eyelids (ptosis), dry eyes, or blurred vision from the injections that outweigh their benefits [2][3].
- You prefer a potentially long-lasting treatment: Some patients choose to pursue surgery because they want to address the root cause of the spasms rather than managing symptoms with lifelong, repeated injections [4][5].
There is no medical rule requiring you to undergo a specific number of Botox injections before exploring surgical options [5].
Diagnostic Evidence: MRI and EMG
Hemifacial spasm is primarily a clinical diagnosis, meaning your doctor diagnoses it based on your symptoms and physical examination. However, testing is necessary to plan for surgery and rule out other problems.
- High-Resolution MRI: You will likely undergo specialized imaging to rule out secondary causes of the spasms, such as tumors or demyelinating diseases [6]. The MRI also maps your anatomy, looking for neurovascular compression—evidence of a blood vessel (an artery or a vein) pressing against the facial nerve [7][8]. However, imaging is not perfect. A negative or inconclusive scan does not automatically rule out MVD if your symptoms are classic; surgeons can often find and treat the compressing vessel during the operation even if it wasn’t clearly visible on the MRI [9][10].
- Electromyography (EMG): An EMG test measures the electrical activity of your facial muscles and looks for an abnormal signal called the lateral spread response. While an EMG can strongly support the diagnosis and distinguish primary hemifacial spasm from other facial movement disorders, it is not a definitive test. A missing lateral spread response does not entirely exclude you from surgery if your clinical symptoms are typical [11].
General Health and the Role of Age
MVD is a major neurosurgical procedure. It uses a “retrosigmoid approach,” meaning the surgeon makes a small opening in the skull behind the ear to operate near the facial, hearing, and balance nerves (rather than cutting into brain tissue).
Because it requires general anesthesia, your overall physical health—including heart and lung function, kidney health, frailty, and the use of blood thinners—is much more important than your chronological age [12]. Age alone is not an automatic exclusion. Research shows that carefully selected older adults, including those over 70, can achieve excellent long-term spasm relief, provided they have good functional reserves and cardiovascular health [5][13].
Weighing the Risks, Rewards, and Recovery
The decision to undergo MVD requires balancing the severity of your daily symptoms against the risks of surgery. Hemifacial spasm can severely impair your ability to drive, read, work, and socialize [14][15].
MVD offers a high chance of durable relief, but it is not an absolute, guaranteed permanent cure. A large analysis of thousands of patients showed that approximately 90.5% were entirely spasm-free at an average follow-up of 1.25 years [13]. Long-term studies show that spasms can occasionally recur years later (around a 10% recurrence rate at 5 years) [14]. Additionally, relief is not always immediate; for about one-quarter of patients, spasms improve gradually over several months [13].
As a candidate, you must be prepared for the recovery process, which typically involves a short hospital stay, and accept the potential surgical risks.
- Temporary or Treatable Complications: These can include cerebrospinal fluid (CSF) leaks, postoperative headaches, nausea, or dizziness.
- Permanent Risks: While relatively rare in experienced hands, risks include permanent facial nerve palsy (1–2%), nonfunctional hearing loss (2–3%), lower cranial nerve dysfunction, and very rarely (0.1%), stroke or life-threatening complications [16][17].
A good candidate understands that results and complication rates vary depending on the surgeon’s experience and the patient’s unique anatomy, and feels that the potential for long-term spasm relief is worth undertaking these risks.
Common questions in this guide
What symptoms and treatment history may make me a candidate for MVD?
Do I have to receive a certain number of Botox injections before MVD surgery?
Can I still have MVD if my MRI or EMG does not show a clear abnormality?
Does my age prevent me from having MVD surgery?
How effective is MVD, and will relief happen right away?
What are the main risks of MVD for hemifacial spasm?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many MVD procedures for hemifacial spasm do you perform each year, and what are your specific rates for permanent facial weakness and hearing loss?
- 2.Based on my overall health and medical history, what are my personal risks for undergoing general anesthesia and major posterior-fossa surgery?
- 3.Will I have a baseline audiogram (hearing test) before surgery so we can monitor for any changes afterward?
- 4.What happens during the operation if you cannot find a clear blood vessel compressing the nerve?
- 5.What proportion of your patients experience immediate relief versus delayed improvement, and what is your long-term recurrence rate?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Clinical Application of Botulinum Toxin for Hemifacial Spasm.
Park CK, Lim SH, Park K
Life (Basel, Switzerland) 2023; (13(8)) doi:10.3390/life13081760.
PMID: 37629617 - 2
Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
Dantas FM, Freire FO, Pessoa Neto AD, et al.
Arquivos de neuro-psiquiatria 2025; (83(1)):1-8 doi:10.1055/s-0044-1793935.
PMID: 39814003 - 3
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm.
Dashtipour K, Chen JJ, Frei K, et al.
Tremor and other hyperkinetic movements (New York, N.Y.) 2015; (5()):338 doi:10.7916/D8CJ8CVR.
PMID: 26566457 - 4
Treatment of Blepharospasm/Hemifacial Spasm.
Green KE, Rastall D, Eggenberger E
Current treatment options in neurology 2017; (19(11)):41 doi:10.1007/s11940-017-0475-0.
PMID: 28965229 - 5
Decompression Surgery in Elderly Patients with Hemifacial Spasm Refractory to Botulinum Toxin.
Tugend M, Ulane CM, Patel K, Sekula RF
Movement disorders clinical practice 2024; (11(8)):966-972 doi:10.1002/mdc3.14064.
PMID: 38779725 - 6
Pivotal Factors for Minimizing the Risks of Therapeutic Failure in Trigeminal Neuralgia and Hemifacial Spasm.
Pătrășcan AM, Brehar FM, Gorgan RM
Current pain and headache reports 2026; (30(1)):27 doi:10.1007/s11916-025-01449-1.
PMID: 41642504 - 7
The value of multimodal imaging fusion in preoperative visualization assessment of neurovascular relationship in hemifacial spasm: a single-center retrospective study.
Wang Y, Li Y, Shi H, et al.
Neurosurgical review 2024; (47(1)):605 doi:10.1007/s10143-024-02872-5.
PMID: 39269622 - 8
Imaging predictors of successful surgical treatment of hemifacial spasm.
Hughes MA, Traylor KS, Branstetter Iv BF, et al.
Brain communications 2021; (3(3)):fcab146 doi:10.1093/braincomms/fcab146.
PMID: 34396106 - 9
Outcomes after Microvascular Decompression for Hemifacial Spasm without Definite Radiological Neurovascular Compression at the Root Exit Zone.
Jeon C, Kim M, Lee HS, et al.
Life (Basel, Switzerland) 2023; (13(10)) doi:10.3390/life13102064.
PMID: 37895445 - 10
Assessment of prevalence of vascular contact of the facial nerve in asymptomatic patients using three-dimensional constructive interference in steady-state (3D CISS) MRI acquisition.
Samanvitha H, Nithish G, Sushmitha Puttappa S, et al.
Polish journal of radiology 2024; (89()):e336-e344 doi:10.5114/pjr/189274.
PMID: 39139255 - 11
Is the pre-operative lateral spread response on facial electromyography a valid diagnostic tool for hemifacial spasm?
Park CK, Lim SH, Lee SH, Park BJ
Neurosurgical review 2021; (44(6)):3259-3266 doi:10.1007/s10143-020-01267-6.
PMID: 33559796 - 12
Hemifacial Spasm: Comparison of Results between Patients Older and Younger than 70 Years Operated on with Microvascular Decompression.
Zhao H, Zhu J, Tang YD, et al.
Journal of neurological surgery. Part A, Central European neurosurgery 2022; (83(2)):118-121 doi:10.1055/s-0040-1721018.
PMID: 34237777 - 13
Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis.
Holste K, Sahyouni R, Teton Z, et al.
World neurosurgery 2020; (139()):e383-e390 doi:10.1016/j.wneu.2020.04.001.
PMID: 32305605 - 14
An investigation into quality of life improvement in patients undergoing microvascular decompression for hemifacial spasm.
Lawrence JD, Frederickson AM, Chang YF, et al.
Journal of neurosurgery 2018; (128(1)):193-201.
PMID: 28186450 - 15
Hemifacial spasm: an update on pathophysiology, investigations and management.
Jesuthasan A, Natalwala A, Davagnanam I, et al.
Journal of neurology 2025; (272(8)):502 doi:10.1007/s00415-025-13220-y.
PMID: 40640398 - 16
Microvascular decompression for hemifacial spasm: Outcome on spasm and complications. A review.
Sindou M, Mercier P
Neuro-Chirurgie 2018; (64(2)):106-116 doi:10.1016/j.neuchi.2018.01.001.
PMID: 29454467 - 17
Operative Complications of Microvascular Decompression for Hemifacial Spasm: Experience of 1548 Cases.
Zhao H, Zhang X, Tang YD, et al.
World neurosurgery 2017; (107()):559-564 doi:10.1016/j.wneu.2017.08.028.
PMID: 28823667
This page explains factors doctors consider when evaluating microvascular decompression for hemifacial spasm for informational purposes only and does not constitute medical advice. Discuss your symptoms, overall health, and personal surgical risks with a qualified neurosurgeon.
Get notified when new evidence is published on Hemifacial spasm.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.